ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Organ Systems Program Success With Concepts Continues as DBD, DCE Boards Okay Five More

July 3, 1987

News Council Says Post Series “Flawed By Sensationalism”

June 11, 1982

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

February 14, 2014

NCI Moves Ahead To Find “Less-Hazardous” Cigarette

April 19, 1974

As MD Anderson Targets Eight Cancers, Detailed War Plan Remains Under Wraps

September 21, 2012

Healy Sworn In, Calls For ‘Operation Bethesda Storm’

July 12, 1991